FRE — Firebrick Pharma Share News
0.000.00%
Last trade - 00:00- AU$8.56m
- AU$7.23m
- AU$0.11m
Brief: Firebrick Pharma Announces Share Purchase Plan
Australia's Firebrick Pharma tumbles on discounted share purchase plan
Brief: Firebrick Pharma Says New Agreement Allows Nasodine Launch In Philippines
Australia's Firebrick Pharma jumps on Singapore product launch
Australia's Firebrick Pharma climbs to 7-month high on US product launch
Australia's Firebrick Pharma jumps on publication of its COVID-19 trial results
Brief: Firebrick Pharma Says Received Notice Of Allowance Of Second Patent In U.S. On Covid-19
Australia's Firebrick falls on withdrawing appeal for nasal spray approval
Brief: Firebrick Pharma Says Withdrew Its Appeal With Administrative Appeals Tribunal (AAT)
Brief: Firebrick Pharma Ltd Says Nasodine Covid-19 Patent Granted In South Africa
Australia's Firebrick Pharma hits record low on unfavourable nasal spray trial results
Brief: Firebrick Pharma Requests Trading Halt
Brief: Firebrick Pharma Says Firebrick COVID-19 Trial Achieves Primary Endpoint
Brief: Firebrick Pharma Says AAT Conciliation Meeting 1 Has Been Deferred
Brief: Firebrick Pharma Says Nasal Spray Now Allowed In Canada
Australia's Firebrick Pharma hits record low after discounted placement
Brief: Firebrick Pharma Says Raises A$1 Million Via Placement
Brief: Firebrick Pharma Posts HY Loss After Tax Attributable A$3.1 Mln
Brief: Firebrick Pharma Ltd Says Kyla Garic Has Resigned As CFO